TCG Crossover

Funding rounds backed by TCG Crossover.

Export CSV
Funding disclosed in full
$50M
Median round
$50M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Accro Bioscience

Develops novel therapeutics for immune mediated diseases

$50MSeries CBiotechUnited States
6 participantsCenova CapitalLAVOrbiMedOriza HoldingsShenzhen Capital GroupTCG Crossover